Cytek Investor Presentation Deck
Development Strategy for Driving New Applications via Reagents
Work with industry partners
/ KOLs to potentially co-
develop new fluorophores and
antibody conjugates with
unique spectral characteristics
Evaluate unique
fluorophore prototypes
to consider future
development of additional
products or processes
+
+
Leukemia &
Lymphoma Diagnosis
Collaborations with Clinical
Laboratories to design and
study potential clinical
diagnostics
Identify and develop a larger range of conjugated antibodies
that can be combined across each laser to increase the number of colors that can be effectively used together, with
optimal resolution, in laboratory research and clinical diagnostics
Minimal Residual
Disease Monitoring
CYTEK
TRANSCEND THE CONVENTIONAL
20View entire presentation